Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax

Br J Haematol. 2023 Sep;202(5):e39-e42. doi: 10.1111/bjh.18936. Epub 2023 Jun 22.

Authors

Affiliations

¹ Pediatric Oncology and Hematology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
² Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
³ Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

PMID: 37350036
DOI: 10.1111/bjh.18936

No abstract available

Publication types

Letter

MeSH terms

Aniline Compounds
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
Child
Humans
Sulfonamides* / therapeutic use

Substances

venetoclax
navitoclax
Sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
Aniline Compounds